Healthcare / Health Information ServicesStockholm
$219.60
+0.40 (+0.18%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $246.6M · quality 76.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
54/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.5B
P/E
33.6x
↑EV/EBITDA
12.8x
↑ROE
23.1%
↑Gross Margin
92.4%
↑Debt/Equity
0.40
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+16.8%
FCF CAGR
+10.0%
FCF margin
11.8%
FCF / Net income
0.70x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.34B · net income $227.8M · FCF $158.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.34B | $1.34B | $1.19B | $1.02B | $843.6M |
| Net Income | $227.8M | $227.8M | $203.5M | $81.6M | $23.8M |
| EBITDA | $586.8M | $586.8M | $571.3M | $405.9M | $340.8M |
| EPS | 6.65 | 6.65 | 5.94 | 2.38 | 0.69 |
| Gross Margin | 92.4% | 92.4% | 91.7% | 89.6% | 88.7% |
| Operating Margin | 24.5% | 24.5% | 21.1% | 12.0% | 3.6% |
| Net Margin | 16.9% | 16.9% | 17.1% | 8.0% | 2.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.40 | 0.40 | 0.54 | 0.72 | 0.85 |
| Current Ratio | 1.79 | 1.79 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $158.9M | $158.9M | $267.6M | $246.6M | $119.3M |
| Returns | |||||
| ROE | 23.1% | 23.1% | 23.2% | 11.1% | 3.6% |
| Valuation | |||||
| P/E | 33.58 | 33.58 | 37.04 | 36.64 | 104.35 |
| EV/EBITDA | 12.81 | 12.81 | 13.22 | 7.82 | 8.40 |
| P/B | 7.64 | 7.64 | 8.60 | 4.07 | 3.76 |
| Growth & Yield | |||||
| Revenue Growth | 12.8% | 12.8% | 16.6% | 21.2% | — |
| EPS Growth | 12.0% | 12.0% | 149.6% | 244.9% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
43.1%
EPS terminal req.
$19.49
Spread vs growth
-31.1%
5Y implied EPS CAGR
28.8%
EPS terminal req.
$23.58
Spread vs growth
-16.9%
10Y implied EPS CAGR
19.0%
EPS terminal req.
$37.97
Spread vs growth
-7.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-26.9%
Start / end P/E
51.9x → 33.0x
EPS bridge
5.94 → 6.65
Residual
-4.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.